| Literature DB >> 12879345 |
Leslie N Sutton1, N Scott Adzick, Mark P Johnson.
Abstract
INTRODUCTION: Although in utero treatment of myelomeningocele shows promise in decreasing the morbidity of this disease, the risks to the fetus are significant, and the benefits are unproven. TRIAL: The upcoming trial represents one of the few times that the pediatric neurosurgical community has come together to test a new procedure.Entities:
Mesh:
Year: 2003 PMID: 12879345 DOI: 10.1007/s00381-003-0787-0
Source DB: PubMed Journal: Childs Nerv Syst ISSN: 0256-7040 Impact factor: 1.475